An acquisition means integration work is about to be scoped. Fundz scores the company against what you sell, and says why it matched.See it live →
UCLA Health Jonsson Comprehensive Cancer Center receives $3.9M grant from NCI to develop cancer immunotherapy strategies for melanoma treatment.
Sep 19, 2026•about 3 hours ago
Los AngelesBiotechnologyHealth CareMedical
Description
Cristina Puig-Saus and her research team at UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3.9 million grant from the National Cancer Institute (NCI). The funding will support the development of drug-based strategies to enhance cancer immunotherapy for patients with melanoma and potentially other cancer types. The grant reflects NCI's commitment to advancing innovative cancer treatment approaches.
Company Information
Company
UCLA Health Jonsson Comprehensive Cancer Center
Location
Los Angeles, California, United States
About
Cristina Puig-Saus and her research team at UCLA are developing drug-based strategies to enhance cancer immunotherapy for melanoma and other cancer types. The team includes faculty from the David Geffen School of Medicine at UCLA and researchers from the UCLA Health Jonsson Comprehensive Cancer Center, focusing on innovative approaches to improve patient outcomes.
Predictive Intelligence
Strategic
ML-powered predictions for UCLA Health Jonsson Comprehensive Cancer Center's next move